“PATHOLOGICAL OUTCOME OF HER2 NEU-POSITIVE EARLY BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY”. Frontier in Medical and Health Research, vol. 3, no. 7, Sept. 2025, pp. 1552-8, https://fmhr.net/index.php/fmhr/article/view/1887.